MoneyWorks4Me

Godavari Drugs - Quaterly Results

28 May 2026 Evaluate
The sales moved up 30.04% to Rs. 331.63 millions for the March 2026 quarter as compared to Rs. 255.03 millions during the year-ago period.A comparatively good net profit growth of 44.34% to Rs. 12.89 millions was reported for the quarter ended March 2026 compared to Rs. 8.93 millions of previous same quarter.The company reported a degrowth in operating Profit to 30.80 millions from 32.19 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 331.63 255.03 30.04 1058.08 1133.50 -6.65 1058.08 1133.50 -6.65
Other Income 1.41 1.05 34.29 8.05 9.77 -17.60 8.05 9.77 -17.60
PBIDT 30.80 32.19 -4.32 111.19 128.04 -13.16 111.19 128.04 -13.16
Interest 9.56 11.07 -13.64 39.80 47.32 -15.89 39.80 47.32 -15.89
PBDT 22.28 21.12 5.49 74.94 80.72 -7.16 74.94 80.72 -7.16
Depreciation 6.12 6.72 -8.93 24.32 24.48 -0.65 24.32 24.48 -0.65
PBT 16.16 14.40 12.22 50.62 56.24 -9.99 50.62 56.24 -9.99
TAX 3.27 5.47 -40.22 9.74 12.45 -21.77 9.74 12.45 -21.77
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 12.89 8.93 44.34 40.88 43.79 -6.65 40.88 43.79 -6.65
Equity 101.27 75.30 34.49 101.27 75.30 34.49 101.27 75.30 34.49
PBIDTM(%) 9.29 12.62 -26.42 10.51 11.30 -6.97 10.51 11.30 -6.97
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..